Greg Schiffman has left his various senior executive positions at Affymetrix to take on the role of senior vice president and chief financial officer at Dendreon, a Seattle-based drug developer.
Affymetrix said last week that Schiffman resigned, effective immediately, from his posts as executive vice president, chief financial officer, and treasurer, as well as other positions he holds at Affy subsidiaries.
The company said James Gibson will take over the role of principal accounting officer from his position as vice president of accounting and corporate controller. Gibson formerly served as director of finance and controller at Netflix.
Affy said it intends to start seeking candidates for CFO and principal financial officer immediately.
Before working at Affymetrix, Schiffman held vice president positions at Applied Biosystems, Hewlett Packard, and IBM.
John Rayson was recently named chairman of Med BioGene, the company said.
Rayson has been a director of the Canadian biotech since 2004. Rayson practiced family medicine for 27 years before joining MDS Metro Laboratory Services in 1994 as president and CEO, a position he held until 2001 when he became executive vice chairman and CEO.
Rayson ended his tenure as CEO at MDS this year, although he remains executive vice chairman of that company.
|Note to Readers:
This is the last issue of BioArray News to publish in 2006. The next issue of the newsletter will appear on Tuesday, Jan. 2.